www.cancerindetail.com

Late Stage Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of Cancer Survival Among...

3 hrs ago | news.yahoo.com

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, HPV-positive head and neck cancer, a promising multiple myeloma vaccine, and predictive... Read more...
All similar articles: 77 >>

Sinai cancer patient Mount survival treatment CyNx chemoradiotherapy HPV-positive vaccine Oncology Galsky Myeloma predictive tumor Hematology PARADIGM

Skin Metastasis Lung, Colon, Melanoma, Renal

3 hrs ago | dottort.com

Dr. Shane Chapman, MD discusses Skin Metastasis Lung , Colon , Melanoma , Renal . See more at www.dermnet.com PLEASE RATE AND COMMENT!!! LUNG Historically, lung carcinoma is more common in men than women. There is a localized... Read more...

Dottor T colon melanoma metastasis lung skin cutaneous renal carcinoma nodule metastatic

How can an Urologist help you?

12 hrs ago | goarticles.com

Urologist is a physician who treats, determines and performs assessments on the human urinary system tract. This consultant treats both female and male patients in an array of ages. The actual urinary tract is made ... Read more...

Urologist kidney tract urinary genitourinary stone prostate urethra UTI organ urology impotent

Drug Fails: At Least It's Approved Already

16 hrs ago | fool.com

Watch stocks you care about The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Usually cancer drugs go after patients with no... Read more...

Brian Orelli Torisel Pfizer patient approve second-line drug first-line kidney cancer fail Sutent Nexavar treatment trial Torisel-treated least

Aveo kidney cancer drug more tolerated than Nexavar

18 hrs ago | reuters.com

Patients taking a kidney cancer drug being developed by Aveo Pharmaceuticals Inc were half as likely to need a break from the medication due to side effects than those on the widely used medicine Nexavar, according to data... Read more...

Bill Berkrot Nexavar Aveo tivozanib kidney Motzer cancer patient drug PFS

AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in...

19 hrs ago | finanznachrichten.de

Tivozanib is the First Agent to Demonstrate Greater than One Year PFS in Patients without Prior Systemic Treatment - - First Pivotal Trial vs. Active Targeted Agent in First-Line Advanced RCC - - Study Results Demonstrate... Read more...

tivozanib AVEO TIVO-1 PFS sorafenib Astellas RCC patient superiority study

Distraction opens the door to mistakes

24 hrs ago | mayoclinic.com

I recently spoke at a major medical meeting. As I was firing up my computer, a number of colleagues came up to talk. When it was time for me to speak, I began my presentation. About halfway through, my computer screen went... Read more...

mistake kidney patient computer medical beeper life-or-death care forget left distracted cancerous tragically trivial arising devastation interruption conserve

image

PoemStone: From StocksDiva. Bio Updates.

May 16, 2012 | advfn.com

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75632069 Pfizer Inc (NYSE:PFE) announced the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL^® (temsirolimus) in patients with advanced renal cell carcinoma... Read more...

Inc. NYSE 2012 NASDAQ OTCBB bio 31 result Therapeutics Amex patient Corporation March Company

Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In...

May 15, 2012 | finanzen.net

Pfizer zu myNews hinzufügen Was ist das? Pfizer Inc announced today that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL® (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had... Read more...

TORISEL SUTENT patient Pfizer RCC treatment

Women fare better than men, but need more blood after kidney cancer surgery

May 15, 2012 | bio-medicine.org

DETROIT Women do better than men after surgical removal of part or all of a cancerous kidney, with fewer post-operative complications, including dying in the hospital, although they are more likely to receive blood transfusions... Read more...

kidney surgery Trinh blood gender cancer nephrectomy removal surgical woman man transfusion Quoc-Dien 48172 nephrectomies Vattikuti outcome

Rosetta Genomics Launches miRview Kidney

May 15, 2012 | andhranews.net

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced the commercial launch of miRview® kidney, the Company's advanced microRNA assay that uses... Read more...

Rosetta miRview Genomics RCC kidney microRNA microRNA-based assay tumor

InPlay: Uranium Energy acquires Channen Exploration Project in South Texas

May 15, 2012 | finance.yahoo.com

8:58AM Sinclair Broadcast enters into a long-term affiliation agreement with the Fox Broadcasting Company; obtains option to acquire Fox owned station in Baltimore 9.30 : Co announced that it has entered into an agreement with... Read more...

Sinclair affiliation acquire miRview 8:58AM station Texas inContact mln assignable FTS microRNA kidney Fox Genomics Rosetta option Baltimore agreement $52.7 Broadcasting

Peter Andre - Peter Andre Plans Post-chemo Break For Brother

May 15, 2012 | contactmusic.com

Peter Andre is planning to take his brother away on vacation when he has completed chemotherapy The singer and reality TV star has been keeping a vigil by his sibling Andrews bedside while he has been treated for kidney cancer... Read more...

Andre Peter brother chemotherapy Andrew birthday Post-Chemo safari curry kidney holiday

image

Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual...

May 14, 2012 | finanznachrichten.de

Data from Kidney Cancer Portfolio Further Demonstrate Efficacy and Safety Across Multiple Lines of Therapy Additional Results from Investigational Compounds in Early- and Late-Stage Development Will Also Be Featured New data... Read more...

Pfizer axitinib ASCO cancer RCC present Oncology kidney lung data advanced metastatic AGILE Abstract evaluating Sutent sorafenib kinases

3SBIO INC Earnings Call scheduled for 8:00 am ET today

May 14, 2012 | biz.yahoo.com

3SBIO INC Earnings Conference Call (Q1 2012) Scheduled to start Mon, May 14, 2012, 8:00 am Eastern -- this event is ongoing now-- 3SBio Inc., a biotechnology company, engages in the research, development, manufacture, and... Read more...

3SBIO INC Earnings EPIAO 8:00 recombinant Call TPIAO carcinoma metastatic anemia renal product iron patient treat

ASCO Preview: Eight Cancer Drugs to Watch at the Big Show

May 14, 2012 | xconomy.com

The pistons of the biggest publicity engine in cancer R&D will start firing this week. It’s time to behold the annual rite of the American Society of Clinical Oncology (ASCO) meeting, the biggest event for showing off what’s... Read more...

Luke Timmerman ASCO cancer drug Genentech Aveo T-DM1 regorafenib tivozanib preview tumor Pharmaceuticals

Pension Annuity Proposal Form

May 12, 2012 | docstoc.com

shared by: rossir24 on: Saturday, May 12, 2012 Pension Annuity Proposal FormPlan your retirement PART A – Personal Information Proposal for a Pension Annuity Policy The Policy is to be purchased by the Administrator using the... Read more...

Cond No Yes 3 please

Man sues UCSD over cancerous kidney transplant

May 12, 2012 | abclocal.go.com

A San Diego County man who received a cancerous kidney during a transplant goes to court next week against the doctor who performed the operation. Austin Scalf received the kidney back in 2008. But just two weeks after the... Read more...

kidney UCSD cancerous transplant Scalf sue cyst abc7newsbayarea

Logans Hatcher optimistic after health scare

May 10, 2012 | wvgazette.com

COACHING GETS in your blood, and its hard to get it out. Here was Mark Hatcher, a few hours removed from a visit to the Cleveland Clinic for diagnosis of possible kidney cancer and impending surgery, and what was he thinking... Read more...

Hatcher kidney Logan health hopefully coach

An Anti-Cancer Drug that Stunts Tumor Growth

May 9, 2012 | anl.gov

An anti-cancer drug, pazopanib, which is marketed as Votrient™ in the U.S. and Europe by its developer, GlaxoSmithKline, was developed in part by research at the U.S. Department of Energy’s Advanced Photon Source at Argonne... Read more...

Argonne pazopanib Votrient™ blood vessel Photon kidney tumor APS carcinoma IMCA-CAT renal treatment scientific quinazoline drug GlaxoSmithKline cytokine-based inhibitor prior Department of Energy Hauptman-Woodward cancer multikinase

image

Canada's cancer death rate falling, report says

May 9, 2012 | ctv.ca

The death toll cancer takes in Canada is on the decline, fuelled in large part by the fact that lung cancer is killing fewer Canadian men than it did in earlier decades, the Canadian Cancer Society said Wednesday. Read more...
All similar articles: 140 >>

cancer rate death Bromfield lung Canadian Canada smoking falling breast cent Society

image

Compulsory licensing sets off a wave of price cuts in cancer drugs

May 8, 2012 | livemint.com

In 2010, about 600,000 people in the country died of cancer, according to a recent joint study by the Tata Memorial Hospital and the Centre for Global Health Research Mumbai: Prices of cancer medicines are dropping dramatically... Read more...

cancer drug compulsory patent Natco price licensing Roche Cipla lakh India maker Novartis Bayer generic

Targeted Therapies Drive the Global Renal Cell Carcinoma (RCC) Drugs...

May 7, 2012 | prweb.com

GIA announces the release of a comprehensive global report on the Kidney Cancer Drugs markets. The global market for Renal Cell Carcinoma (RCC) Drugs is forecast to reach $3.03 billion by the year 2017, driven by the growing... Read more...

RCC kidney therapy cancer drug targeted Drugs Inhibitors Multikinase mTOR GIA global Carcinoma Analysts Renal

Bayer Appeals India Patent Ruling

May 5, 2012 | bullfax.com

Germany's Bayer has appealed against the grant of a compulsory license by India's patent authority to a local generic drug producer for its kidney- and liver-cancer medicine, Nexavar. India's patent authority forced Bayer to... Read more...

Bayer patent India appeal Curis Nexavar kidney submits:Try cancer compulsory liver-cancer BAYRY.PK liver Mishaps Drug generic CRIS

India slashes cancer drug price

May 4, 2012 | skynews.com.au

Updated: 08:01, Saturday May 5, 2012 Indian drugs giant Cipla says it has slashed by up to 76 per cent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a 'humanitarian move'.... Read more...
All similar articles: 64 >>

drug cancer India Cipla slash Bayer price Hamied generic Nexavar $A5375 $A171 $A127 Soranib sell reduction rupee

image

Votrient Improves Progression-free Survival in Advanced Kidney Cancer

May 4, 2012 | directorym.com

The kidneys are filled with tiny tubules that clean and filter the blood; this process removes waste and makes urine. Renal cell cancer (RCC) is a malignancy involving these tubules of the kidney. It is the most common type of... Read more...

Votrient kidney cancer tubule RCC malignancy

Why We Must Ration Health Care

May 3, 2012 | boston.com

By Peter Singer July 19, 2009 You have advanced kidney cancer. It will kill you, probably in the next year or two. A drug called Sutent slows the spread of the cancer and may give you an extra six months, but at a cost of... Read more...
All similar articles: 67 >>

Peter Singer health care insurance Sutent ration rationing drug NICE Rosser cost patient treatment

The Ideal Secrets And Techniques For Troxerutin

May 3, 2012 | health-niche-articles.com

Cancer and its cure has been an lively region of investigate and a lot of new medications are in clinical trials in purchase to come across an efficacious drug in opposition to cancer having least facet results. In addition to... Read more...

Rapamycin Troxerutin immunosuppressing mTOR inhibitor cancer drug transplantation

Women at High Risk for Breast Cancer May Benefit from Starting Mammography at Age 40

May 2, 2012 | cancer.gov

For women with twice the average risk of developing breast cancer, the benefits and harms of beginning biennial (every-other-year) screening mammography at age 40 are similar to those for average-risk women aged 50 to 74... Read more...

nephrectomy patient survival cancer Jude NSCLC whites partial white Hispanic disparity study kidney non-Hispanic NCI subtype breast SEER St. researcher

Majority of gene faults not shared across other biopsies from same tumour

May 2, 2012 | news-medical.net

Published on May 2, 2012 at 6:21 AM · Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine today... Read more...

tumor biopsy cancer fault kidney gene mutation genetic majority Research sample